Pubertal development in HIV-infected African children on first-line antiretroviral therapy.

Eitemau Tebyg

• Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.
  gan: Bwakura-Dangarembizi, M, et al.
  Cyhoeddwyd: (2015)
• Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
  gan: Crook, A, et al.
  Cyhoeddwyd: (2016)
• Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.
  gan: Kekitiinwa, A, et al.
  Cyhoeddwyd: (2013)
• Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 years.
  gan: Musoke, P, et al.
  Cyhoeddwyd: (2015)
• Inflammatory biomarkers in HIV-infected children hospitalized for severe malnutrition in Uganda and Zimbabwe
  gan: Prendergast, A, et al.
  Cyhoeddwyd: (2019)